top of page

At Synamics Therapeutics, we are guided by a dedicated team of seasoned leaders, driven by a commitment to put patients at the heart of everything we do. Our leadership roster is composed of experienced entrepreneurs, industry veterans, and globally recognized scientists. Our focus is crystal clear: to revolutionize drug discovery through cutting-edge computational and AI methods. With a patient-centric approach as our driving force, we channel all our efforts into delivering breakthroughs that can transform lives, without delay.

Synamics Founders

Copy of Pitching deck_edited.jpg

Violet Zahedi, MD

  • LinkedIn

Co-Founder & CEO

Copy of Pitching deck-2_edited_edited.jp

Helder Nakaya, PhD

  • LinkedIn

Co-Founder & CSO

Biochemistry and Molecular Biology

Copy of Pitching deck-3_edited.jpg

Albert J. Kooistra, PhD

  • LinkedIn

Co-Founder & CTO

Computational Medicinal Chemistry

Copy of Pitching deck-4_edited_edited.jp

Aaron Capar, MPPA

  • LinkedIn

Co-Founder, CBO & Board Chair

Board of Advisors

Copy of Pitching deck-6_edited.jpg

Bryn-Williams Jones, B.Sc (Hons)

  • LinkedIn

CEO at The Open PHACTS Foundation,

Former SVP of Drug Discovery at BenevolentAI

Copy of Pitching deck-7_edited.jpg
  • LinkedIn

Carsten Niemann, MD, PhD

Associate Professor & Chief Physician, Department of Hematology, Head of CLL Lab, Copenhagen University Hospital, Rigshospitalet

Copy of Pitching deck-5_edited.jpg

Ali Harandi, PhD

  • LinkedIn

Associate Professor & Lab Head, Department of Microbiology and Immunology, University of Gothenburg, Faculty Member University of British Columbia

Copy of Pitching deck-8_edited.jpg
Synamics Therapeutics-3_edited_edited_ed

Lydie Roux, MBA

  • LinkedIn

Jes Broeng, PhD

  • LinkedIn

VP Business Operations GSK France, Former Executive at Novo Nordisk and MSD 

Professor & Director, DTU Entrepreneurship, Programme Director for Open Entrepreneurship, Technical University of Denmark

bottom of page